Chemoinformaics analysis of 2,2-Dimethyl-1-hexanol
| Molecular Weight | 130.231 | nRot | 4 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 0 |
| Exact Molecular Weight | 130.136 | nRing | 0 |
| Solubility: LogS | -2.078 | nHRing | 0 |
| Solubility: LogP | 2.843 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 26.1643 |
| nHD | 1 | BPOL | 18.0577 |
| QED | 0.618 |
| Synth | 2.271 |
| Natural Product Likeliness | 0.833 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.167 |
| MDCK | 0.0000194 |
| BBB | 0.978 |
| PPB | 0.784173 |
| VDSS | 1.005 |
| FU | 0.411627 |
| CYP1A2-inh | 0.567 |
| CYP1A2-sub | 0.812 |
| CYP2c19-inh | 0.253 |
| CYP2c19-sub | 0.865 |
| CYP2c9-inh | 0.078 |
| CYP2c9-sub | 0.65 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.534 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.201 |
| CL | 8.999 |
| T12 | 0.639 |
| hERG | 0.03 |
| Ames | 0.007 |
| ROA | 0.04 |
| SkinSen | 0.324 |
| Carcinogencity | 0.083 |
| EI | 0.971 |
| Respiratory | 0.197 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.94617 |